Veterinary Anesthesia Equipment Market

To ensure safe and effective anesthesia during surgery, veterinary anesthesiologists require various medical supplies. Veterinary anesthesia equipment is among the collections available. In addition, veterinary anesthesiologists use Anesthetics to reduce or eliminate pain in animals before, during, and after surgery.

Because of its widespread use in human and veterinary surgeries, the general anesthesia segment is expected to account for the largest share of the veterinary anesthesia equipment market. This segment is also likely to snowball due to increased awareness of its benefits among practitioners and patients.

Due to increased awareness about anesthesia among pet owners in this region, Asia Pacific is expected to be the fastest-growing veterinary anesthesia equipment market during 2018–2031. North America is also expected to grow at a healthy rate but will face competition from Asia Pacific in the coming years as Asian economies continue to grow. Europe is expected to see moderate growth in the future as it focuses more on preventive health care and an aging population, both of which necessitate the regular use of anesthesia procedures for various diseases, such as cancer treatment, among others.

Other significant factors driving the growth of the veterinary anesthesia equipment market include the growing trend toward minimally invasive surgeries and the increasing demand for safe and effective anesthetics in the pet and livestock industries.

The veterinary anesthesia equipment market is divided into two categories: general anesthesia devices and regional anesthesia devices. Available anesthesia devices provide sedation and analgesia, whereas restricted anesthesia devices deliver anesthetics such as propofol or etomidate to specific body areas. General anesthetic devices include inhalers, nitrous oxide cylinders, intravenous pumps, and masks, while regional anesthetic devices include epidural needles and catheters.

Some famous players in this segment include Anesthesiologic Solutions, Ltd. (US), Bupivacaine HCI, Inc. (US), and Laboratorios Andromedicos SRL (Italy).